Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, Mark G. Jones, Coline van Moorsel, Tamera J. Corte, Chiara Romei, Recep Savas, Christopher J. Brereton, Hendrik W. van Es, Helen Jo, Annalisa De Liperi, Omer Unat, Katarina Pontoppidan, Frouke van Beek, Marcel Veltkamp, Peter Hopkins, Yuben Moodley, Alessandro Taliani, Laura Tavanti, Bahareh Gholipour, Arjun Nair, Sam Janes, Iain Stewart, David Barber, Daniel C. Alexander, Athol U. Wells, Joseph Jacob. Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema. ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021

Member's Comments

No comment yet.

Related content which might interest you: The impact of emphysema in pulmonary fibrosis Source: Eur Respir Rev 2013; 22: 153-157 Year: 2013 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Source: Eur Respir J 2005; 26: 586-593 Year: 2005 Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases Year: 2015 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Autoimmunity profile in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Clinical significance of combined pulmonary fibrosis and emphysema Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Clinical features of combined pulmonary fibrosis and emphysema Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012